Making healthcare better is our priority, and we believe medical technology can play an even greater role in improving people’s lives. With challenges facing families and healthcare systems — such as rising costs, aging populations, and the burden of chronic disease — we are using the power of technology to take healthcare Further, Together. Since the late 1940s, we have been working with others to alleviate pain, restore health, and extend life. Today, we are a medical technology leader, employing more than 84,000 people worldwide, and offering therapies and solutions that enable greater efficiency, access, and value for healthcare systems and the people they serve. Learn more at Medtronic.com
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo
We are a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure the diseases we treat. We employ more than 45,000 people in 80 offices around the world, and market our products in 169 countries.
"Founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases."
Ferring Pharmaceuticals is research-driven biopharmaceutical company devoted to identifying, developing and marketing innovative products in the fields of Urology, Reproductive Health, Gastroenterology & Endocrinology.Ferring Pharmaceuticals is offering a leading portfolio of products in its key therapeutic areas, to provide tailored treatments that function on the body’s own terms.
At Johnson & Johnson Medical Devices Companies, we are using our breadth, scale and experience to reimagine the way healthcare is delivered and to help people live longer, healthier lives.
In a radically changing environment, we are making connections across science and technology to combine our own expertise in surgery with the big ideas of others to design and deliver doctor and patient-centric products and solutions.
As pioneers in medical devices, we continually focus on elevating the standard of care – working to expand patient access, improve outcomes, reduce health system costs and drive value. We create smart, people-centered healthcare to help the patients we serve recover faster and live longer and more vibrantly.
We are in this for life.
SAJA is a joint venture between the premier Saudi healthcare company Tamer Industries and two of the leading Japanese Pharmaceutical companies which are Daiichi Sankyo Company Ltd and Astellas Pharma Inc.
Together with the Japanese partners, SAJA have invested in the most advanced pharmaceutical production facility yet seen in the Middle East designed and built in strict accordance with Japanese standards, to the highest specifications.
SAJA was established in 1996 and introduced the first product to Saudi market in 2000. Since then, SAJA is expanding geographically and diversifying its unique portfolio, SAJA plant is locally manufacturing medicines of a superior quality and exporting them throughout the Middle East and other regions.
AL NOZHA MEDICAL FZE. Was established in 2007 at the Saif zone / Free Zone in Sharjah, UAE.
The mother company AL-NOZHA MEDICAL EST in Jeddah Saudi Arabia, was established in 1991.
We are active in the Niche Medical Distribution with an office and warehouse in the Saif zone.
Our local UAE distributor is Metrics Medical Trading L.L.C, in Abu Dhabi.
Quadri Pharma is a pharmaceutical business organization that was originally established in Egypt back in 1994. The organization was setup with the goal to provide professional and reliable technical services to principals while covering: registration, marketing & distribution of products in total compliance to local and international regulatory standards.